← All investors

RV

Firm & fund profile / Sourced portfolio

Redpoint Ventures

Tracked participation in 6 Atlas companies, with 3 explicitly attributed leads.

Firm website ↗

6portfolio companies

13round participations

3lead positions

$521Mled round total

Conviction

Most recent leads

The latest rounds this investor is sourced as leading, newest first.

May 2026ModalSeries C$355Mat $4.7B valuation Feb 2024AbridgeSeries C$150M Oct 2023ModalSeries A$16M

Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner

MModal$4.7BOct 2023 → May 20262 rounds2 led—

LLegora$5.6BMay 2025 → Mar 20263 roundsParticipant—

AAbridgeApplicationsAbridge is a private, enterprise-grade healthcare AI company focused on “clinical conversation intelligence”:…$757.5MraisedRecent roundsStrategic / corporate minority investment (undisclosed amount) · Jun 2026Eli Lilly and Company, NVIDIASeries E · Jun 2025$300M · led by Andreessen HorowitzSeries D · Feb 2025$250M · Bessemer Venture Partners, California Health Care Foundation +10Abridge—Feb 2024 → Feb 20252 rounds1 led—

PIPhysical Intelligence$2.4BNov 2024 → Nov 20241 roundParticipant—

PPoolside$3BMay 2023 → Oct 20242 roundsParticipant—

DDescript$550MSep 2019 → Nov 20223 roundsParticipant—

DateCompanyRoundRaisedValuationRoleEvidence

May 21, 2026MModalSeries C$355M$4.7BLead

Mar 10, 2026LLegoraSeries D$550M$5.6BParticipant

Oct 30, 2025LLegoraSeries C$150M$1.8BParticipant

May 21, 2025LLegoraSeries B$80M$675MParticipant

Feb 17, 2025AAbridgeApplicationsAbridge is a private, enterprise-grade healthcare AI company focused on “clinical conversation intelligence”:…$757.5MraisedRecent roundsStrategic / corporate minority investment (undisclosed amount) · Jun 2026Eli Lilly and Company, NVIDIASeries E · Jun 2025$300M · led by Andreessen HorowitzSeries D · Feb 2025$250M · Bessemer Venture Partners, California Health Care Foundation +10AbridgeSeries D$250M—Participant

Nov 04, 2024PIPhysical IntelligenceSeries A$400M$2.4BParticipant

Oct 02, 2024PPoolsideSeries B$500M$3BParticipant

Feb 23, 2024AAbridgeApplicationsAbridge is a private, enterprise-grade healthcare AI company focused on “clinical conversation intelligence”:…$757.5MraisedRecent roundsStrategic / corporate minority investment (undisclosed amount) · Jun 2026Eli Lilly and Company, NVIDIASeries E · Jun 2025$300M · led by Andreessen HorowitzSeries D · Feb 2025$250M · Bessemer Venture Partners, California Health Care Foundation +10AbridgeSeries C$150M—Lead

Oct 10, 2023MModalSeries A$16M—Lead

May 01, 2023PPoolsideSeed$26M$130MParticipant

Nov 15, 2022DDescriptSeries C$50M$550MParticipant

Jan 13, 2021DDescriptSeries B$30M—Participant

Sep 18, 2019DDescriptSeries A$15M—Participant

DateCompanyRoundRaisedValuationRoleEvidence

Mar 10, 2026LLegoraSeries D$550M$5.6BParticipant

Oct 02, 2024PPoolsideSeries B$500M$3BParticipant

Nov 04, 2024PIPhysical IntelligenceSeries A$400M$2.4BParticipant

May 21, 2026MModalSeries C$355M$4.7BLead

Feb 17, 2025AAbridgeApplicationsAbridge is a private, enterprise-grade healthcare AI company focused on “clinical conversation intelligence”:…$757.5MraisedRecent roundsStrategic / corporate minority investment (undisclosed amount) · Jun 2026Eli Lilly and Company, NVIDIASeries E · Jun 2025$300M · led by Andreessen HorowitzSeries D · Feb 2025$250M · Bessemer Venture Partners, California Health Care Foundation +10AbridgeSeries D$250M—Participant

Oct 30, 2025LLegoraSeries C$150M$1.8BParticipant

Feb 23, 2024AAbridgeApplicationsAbridge is a private, enterprise-grade healthcare AI company focused on “clinical conversation intelligence”:…$757.5MraisedRecent roundsStrategic / corporate minority investment (undisclosed amount) · Jun 2026Eli Lilly and Company, NVIDIASeries E · Jun 2025$300M · led by Andreessen HorowitzSeries D · Feb 2025$250M · Bessemer Venture Partners, California Health Care Foundation +10AbridgeSeries C$150M—Lead

May 21, 2025LLegoraSeries B$80M$675MParticipant

Nov 15, 2022DDescriptSeries C$50M$550MParticipant

Jan 13, 2021DDescriptSeries B$30M—Participant

May 01, 2023PPoolsideSeed$26M$130MParticipant

Oct 10, 2023MModalSeries A$16M—Lead

Sep 18, 2019DDescriptSeries A$15M—Participant